OMB Home White House Website

Agency:    Department of Defense--Military
Bureau:    Research, Development, Test, and Evaluation
Account:    Research, development, test, and evaluation, Army (21-2040)
Certifying Official:    Deputy Comptroller Program/Budget
Contact Information:    http://WWW.DOD.GOV   703-697-5131
Combat Casualty Care for Battlefield Wounds

1 recipient will receive $2,684,000. This is a first-time earmark.
Year Enacted: 2005
Description: We propose to conjugate antimicrobial and pain relief agents to the chitosan biopolymer backbone in order to increase the functionality of field-applied dressings and bandages. It is proposed to use Resodyn Corporation`s novel ResonatAcoustics mixing technology as the basis for a highly productive cell culture vaccine production system. This fundamentally new bioreactor concept opens the way to develop new, highly productive cell culture methods for vaccine production that can increase the speed and reduce the cost of vaccine production.
Beneficiary/Recipient Amount ($K) Program Type Address
Resodyn Corporation $2,684 For-Profit
Butte, MT
Source: Appropriations Report Language - Conference
Reference: 108-622
Location: Line 29, Page 256
Citation Excerpt: Combat Casualty Care for Battlefield Wounds

Last Modified: 16-Apr-2007

Federal Register    |   Jobs at OMB   |   FOIA   |  OMB Locator   |   |   Accessibility   |   Privacy Policy   |   Site Search   |   Help